Post by Bio-Works Technologies

🧬 𝐓𝐚𝐜𝐤𝐥𝐢𝐧𝐠 the anti-obesity downstream bottleneck in Hangzhou! The global demand for anti-obesity therapeutics and 𝐆𝐋𝐏-𝟏 analogues is pushing biomanufacturing to its limits. As developers know, synthesizing a complex peptide is 𝗼𝗻𝗹𝘆 the first step—purifying it at commercial scale without sacrificing flow rates is where the real 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞 lies. To 𝐝𝐢𝐬𝐜𝐮𝐬𝐬 solutions to these exact bottlenecks, Bio-Works is heading to The 6𝙩𝙝 𝙋𝙚𝙥𝙩𝙞𝙙𝙚 𝙖𝙣𝙙 𝘼𝙣𝙩𝙞-𝙊𝙗𝙚𝙨𝙞𝙩𝙮 𝘿𝙚𝙫𝙚𝙡𝙤𝙥𝙚𝙧𝙨 𝙎𝙪𝙢𝙢𝙞𝙩 in Hangzhou, China, on April 16-17. 𝐓𝐨𝐠𝐞𝐭𝐡𝐞𝐫 with our strategic partner, Zenmindes Biotechnology Co,. Ltd, we are excited to connect with local developers and showcase how the high resolution and mechanical rigidity of 𝐖𝐨𝐫𝐤𝐁𝐞𝐚𝐝𝐬™ can simplify scale-up for these critical molecules. With our doubled production capacity in Sweden and Zenmindes’ strong local presence, we are ready to 𝐞𝐧𝐬𝐮𝐫𝐞 true Security of Supply for the growing peptide market. #AntiObesity #GLP1 #PeptidePurification #DownstreamProcessing #Biopharma #BioWorks #Zenmindes